Skip to main navigation Skip to search Skip to main content

Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection

  • Rohan Merani
  • , Mark W. Johnson
  • , Colin A. McCannel
  • , Harry W. Flynn
  • , Ingrid U. Scott
  • , Alex P. Hunyor

Research output: Contribution to journalReview articlepeer-review

Abstract

Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalJournal of VitreoRetinal Diseases
Volume6
Issue number6
DOIs
StatePublished - Nov 1 2022

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection'. Together they form a unique fingerprint.

Cite this